247 related articles for article (PubMed ID: 23555261)
1. TIM-3 does not act as a receptor for galectin-9.
Leitner J; Rieger A; Pickl WF; Zlabinger G; Grabmeier-Pfistershammer K; Steinberger P
PLoS Pathog; 2013 Mar; 9(3):e1003253. PubMed ID: 23555261
[TBL] [Abstract][Full Text] [Related]
2. Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection.
Elahi S; Niki T; Hirashima M; Horton H
Blood; 2012 May; 119(18):4192-204. PubMed ID: 22438246
[TBL] [Abstract][Full Text] [Related]
3. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy.
Yang R; Sun L; Li CF; Wang YH; Yao J; Li H; Yan M; Chang WC; Hsu JM; Cha JH; Hsu JL; Chou CW; Sun X; Deng Y; Chou CK; Yu D; Hung MC
Nat Commun; 2021 Feb; 12(1):832. PubMed ID: 33547304
[TBL] [Abstract][Full Text] [Related]
4. Splenic CD4
Huang N; Zhou R; Chen H; Zhang S; Li J; Wei W; Sun J; Ren S; Li B; Deng H; Yang J; Ji F; Li Z
Int J Immunopathol Pharmacol; 2021; 35():20587384211061051. PubMed ID: 34930041
[No Abstract] [Full Text] [Related]
5. CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.
Huang YH; Zhu C; Kondo Y; Anderson AC; Gandhi A; Russell A; Dougan SK; Petersen BS; Melum E; Pertel T; Clayton KL; Raab M; Chen Q; Beauchemin N; Yazaki PJ; Pyzik M; Ostrowski MA; Glickman JN; Rudd CE; Ploegh HL; Franke A; Petsko GA; Kuchroo VK; Blumberg RS
Nature; 2015 Jan; 517(7534):386-90. PubMed ID: 25363763
[TBL] [Abstract][Full Text] [Related]
6. Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C.
Osuch S; Laskus T; Berak H; Perlejewski K; Metzner KJ; Paciorek M; Radkowski M; Caraballo Cortés K
Sci Rep; 2020 Sep; 10(1):16060. PubMed ID: 32994477
[TBL] [Abstract][Full Text] [Related]
7. Blockade of PD-1 and TIM-3 immune checkpoints fails to restore the function of exhausted CD8
Rezazadeh H; Astaneh M; Tehrani M; Hossein-Nataj H; Zaboli E; Shekarriz R; Asgarian-Omran H
Immunol Res; 2020 Oct; 68(5):269-279. PubMed ID: 32710227
[TBL] [Abstract][Full Text] [Related]
8. Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors.
Okoye I; Xu L; Motamedi M; Parashar P; Walker JW; Elahi S
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33310773
[TBL] [Abstract][Full Text] [Related]
9. Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients.
Shahbazi M; Moulana Z; Sepidarkish M; Bagherzadeh M; Rezanejad M; Mirzakhani M; Jafari M; Mohammadnia-Afrouzi M
Microb Pathog; 2021 Apr; 153():104779. PubMed ID: 33548481
[TBL] [Abstract][Full Text] [Related]
10. CXCR5 and TIM-3 expressions define distinct exhausted T cell subsets in experimental cutaneous infection with
Diupotex M; Zamora-Chimal J; Gajón JA; Bonifaz LC; Becker I
Front Immunol; 2023; 14():1231836. PubMed ID: 37691941
[TBL] [Abstract][Full Text] [Related]
11. Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis.
Kang J; Wei ZF; Li MX; Wang JH
J Biosci; 2020; 45():. PubMed ID: 32345786
[TBL] [Abstract][Full Text] [Related]
12. The role of Tim-3/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma.
Chen Z; Dong D; Zhu Y; Pang N; Ding J
FASEB J; 2021 Mar; 35(3):e21401. PubMed ID: 33559190
[TBL] [Abstract][Full Text] [Related]
13. Galectin-9 and VISTA Expression Define Terminally Exhausted T Cells in HIV-1 Infection.
Shahbaz S; Dunsmore G; Koleva P; Xu L; Houston S; Elahi S
J Immunol; 2020 May; 204(9):2474-2491. PubMed ID: 32205423
[TBL] [Abstract][Full Text] [Related]
14. Highly proliferative and functional PD-1
Batorov EV; Aristova TA; Pronkina NV; Sergeevicheva VV; Sizikova SA; Ushakova GY; Shevela EY; Ostanin AA; Chernykh ER
Int Immunopharmacol; 2021 Nov; 100():108093. PubMed ID: 34474273
[TBL] [Abstract][Full Text] [Related]
15. Tim-3 mediates T cell trogocytosis to limit antitumor immunity.
Pagliano O; Morrison RM; Chauvin JM; Banerjee H; Davar D; Ding Q; Tanegashima T; Gao W; Chakka SR; DeBlasio R; Lowin A; Kara K; Ka M; Zidi B; Amin R; Raphael I; Zhang S; Watkins SC; Sander C; Kirkwood JM; Bosenberg M; Anderson AC; Kuchroo VK; Kane LP; Korman AJ; Rajpal A; West SM; Han M; Bee C; Deng X; Schebye XM; Strop P; Zarour HM
J Clin Invest; 2022 May; 132(9):. PubMed ID: 35316223
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the protein tyrosine phosphatase PTPN22 for adoptive T cell therapy facilitates CTL effector function but promotes T cell exhaustion.
Teagle AR; Castro-Sanchez P; Brownlie RJ; Logan N; Kapoor SS; Wright D; Salmond RJ; Zamoyska R
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056892
[TBL] [Abstract][Full Text] [Related]
17. Implications of PD-1, Tim-3, and TIGIT Expression for Cancer Immunity and Pancreatic Cancer Prognosis.
Nakayama C; Tanoue K; Idichi T; Shimomura H; Kita Y; Hozaka Y; Shinden Y; Matsushita D; Nakajo A; Arigami T; Mataki Y; Kurahara H; Ohtsuka T
Anticancer Res; 2022 Jul; 42(7):3373-3380. PubMed ID: 35790289
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for T cell immunoglobulin and mucin protein 3 and Toxascaris leonina galectin complex.
Han CW; Jeong MS; Lee HN; Hwang EY; Jang SB
Biochem Biophys Res Commun; 2024 Feb; 697():149544. PubMed ID: 38245927
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the TIM-3/Gal-9 immune checkpoint to tropical parasitic diseases.
Bailly C
Acta Trop; 2023 Feb; 238():106792. PubMed ID: 36509129
[TBL] [Abstract][Full Text] [Related]
20. HIV-1-specific T-cell responses and exhaustion profiles in people with HIV after switching to dual therapy vs. maintaining triple therapy based on integrase inhibitors.
Muñoz-Muela E; Trujillo-Rodríguez M; Serna-Gallego A; Saborido-Alconchel A; Ruiz-Mateos E; López-Cortés LF; Gutiérrez-Valencia A
Biomed Pharmacother; 2023 Dec; 168():115750. PubMed ID: 37871555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]